GLP-1 weight loss and kidney disease
Evidence, monitoring and safety considerations for GLP-1 treatment in chronic kidney disease.
Overview
GLP-1 weight loss and kidney disease
What the evidence says about GLP-1 treatment when kidney function is reduced, how eGFR and creatinine are interpreted during weight loss, and the monitoring that keeps treatment safe.
In this topic
Albuminuria: Tracking Your Progress
How to interpret your urine protein results as your weight decreases.
Anaemia, fatigue and weight loss in CKD
Why tiredness during treatment is not always the medicine, and the blood tests we check before blaming the dose.
Cardiovascular Risk Factors in CKD: The Weight Connection
Understanding how obesity exacerbates cardiovascular risk in chronic kidney disease and why weight loss is a primary preventative strategy.
Fatty Liver and the Kidney
The connection between NAFLD (Non-Alcoholic Fatty Liver Disease) and Chronic Kidney Disease.
GLP-1 Use in Polycystic Kidney Disease
Specific considerations for patients with ADPKD using weight loss medications.
How fluid affects your weight and BMI calculations
Why fluid retention can mask fat loss and how we adjust for oedema in clinical monitoring.
Hydration and GI side effects in CKD
Practical, kidney-aware advice on nausea, vomiting, constipation and fluid intake — including sick-day rules and when to stop waiting and call for help.
Hypertension, Weight, and Renal Health
How weight loss acts as a potent anti-hypertensive treatment in patients with renal impairment.
Inflammation and the 'Renal Gut'
How gut health affects kidney inflammation and how GLP-1s may help.
Lipid Management in CKD
Beyond statins: The role of weight loss in managing cholesterol in renal failure.
Metabolic Syndrome and Chronic Kidney Disease
Treating the root causes: Insulin resistance, dyslipidemia, and renal inflammation.
Obesity-Related Glomerulopathy: Reversing Damage
How excess weight directly damages kidney filters and the clinical evidence for regression through weight loss.
Pre-Pregnancy Weight Optimization in CKD
Preparing for a safe pregnancy with kidney disease through metabolic health.
Psychological Barriers to Weight Loss in CKD
Addressing the mental health challenges of living with a chronic condition while trying to manage weight.
Sarcopenic Obesity in CKD
The danger of "hidden" muscle loss in patients with high BMI and how to lose fat while preserving strength.
Sleep Apnoea in Renal Patients
The link between obesity, obstructive sleep apnoea, and rapid CKD progression.
The role of SGLT2 inhibitors and GLP-1s in CKD
How combination therapy works to protect the kidneys while managing weight and blood sugar.
The Role of SGLT2 Inhibitors and Weight Loss
Combining Flozins and GLP-1s for maximum renal protection.
Uric Acid, Gout, and Weight Loss
Managing gout flares during rapid weight loss in renal patients.